Post-Vaccination Neutralization Responses to Omicron Sub-Variants

Background: The emergence of the Omicron variant (B.1.1.529), which correlated with dramatic losses in cross-neutralization capacity of post-vaccination sera, raised concerns about the effectiveness of COVID-19 vaccines against infection and disease. Several clinically relevant sub-variants subseque...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsen, Henning, Katzmarzyk, Maeva, Higdon, Melissa M., Jiménez, Viviana Cobos, Sitaras, Ioannis, Bar-Zeev, Naor, Knoll, Maria Deloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607453/
https://www.ncbi.nlm.nih.gov/pubmed/36298622
http://dx.doi.org/10.3390/vaccines10101757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607453/
https://www.ncbi.nlm.nih.gov/pubmed/36298622
http://dx.doi.org/10.3390/vaccines10101757

Ejemplares similares